Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

2002 Publications

  1. Bradshaw, T.D., Bibby, M.C., Double, J.A., Fichtner, I., Cooper, P.A., Alley, M.C., Donohue, S., Stinson, S.F., Tomaszewski, J.E., Sausville, E.A. and Stevens, M.F., 2002. Preclinical Evaluation of Amino Acid Prodrugs of Novel Antitumor 2-(4-Amino-3-Methylphenyl)Benzothiazoles. Mol. Cancer Ther. 1:239-246.
  2. Chan, D. C., L. Gera, J.M. Stewart, B. Helfrich, T.L. Zhao, W.Y. Feng, et al., 2002. Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines in vitro and in vivo and Produces Synergistic Growth Inhibition in Combination with Other Antitumor Agents. Clin. Cancer Res., 8, 1280-1287.
  3. Egorin, M. J., T.F. Lagattuta, D.R. Hamburger, J.M. Covey, K.D. White, S.M. Musser,et. al., 2002. Pharmacokinetics, Tissue distribution, and Metabolism of 17-(Dimethylaminoethylamino)- 17-demethoxygeldanamycin (NSC 707545) in CD2F1 Mice and Fischer 344 rats. Cancer Chemother. Pharmacol, 49, 7-19.
  4. Feng, W. Y., K.K. Chan,, & J.M. Covey, 2002. Electrospray LC-MS/MS Quantitation, Stability, and Preliminary Pharmacokinetics of Bradykinin Antagonist Polypeptide B201 (NSC 710295) in the Mouse. J. Pharmaceut. Biomed. Anal., 28, 601-612.
  5. Jia, L. Garza, M. Wong, H. Camden, J. Redelmeier, T. Weitman, S. 2002. Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice. J. Pharm. Biomed Anal. 28: 65-72.
  6. Jia, L. Wong, H. Cerna, C. Weitman, S. 2002. Effect of nanonization on absorption of 301029: Ex vivo and in vivo pharmacokinetic correlations determined by LC/MS. Pharm. Res. 19:1091-1096.
  7. Looareesuwan, S., Oosterhuis, B., Schilizzi, B., Sollie, F., Wilairatana, P., Krudsood, S., et al. (2002). Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. British journal of clinical pharmacology , 53 (5), 492-500.
  8. Zheng, H., C. Jiang, M.H. Chiu, J.M. Covey, & K.K. Chan, 2002. Chiral Pharmacokinetics and Inversion of Enantiomers of a New Quinoxaline Topoisomerase II? Poison in the Rat. Drug Metabol. Dispos., 30, 344-348.
  9. Zheng H., Covey J.M., Tosca P.J., Turner N., Chan K.K. 2002. Chiral High-Performance Liquid Chromatographic Analysis of the Enantiomers of XK469, a New Antitumor Agent, in Plasma and Urine. J. Pharmaceut. Biomed. Anal., 28, 287-294.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov